This study found that TMEFF1 promotes the malignant behavior of endometrial carcinoma cells by activating the MAPK and PI3K/AKT signaling pathways, which is consistent with previous findings in ovarian cancer, suggesting that this generality may be related to the EGF-like domain of TMEFF1 10. Here, EGF is linked to endometrial carcinoma.